Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group

Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma in the Modern Era

(2015) Martin T. King et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group

(2015) Dennis A. Eichenauer et al.   JOURNAL OF CLINICAL ONCOLOGY

Hodgkin Lymphoma, Version 2.2015

(2015) Richard T. Hoppe et al.   Journal of the National Comprehensive Cancer Network

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) D. A. Eichenauer et al.   ANNALS OF ONCOLOGY

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

(2014) Ranjana H. Advani et al.   JOURNAL OF CLINICAL ONCOLOGY

High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

(2013) Meghan Karuturi et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

(2013) S. Hartmann et al.   BLOOD

VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma

(2013) Dennis A. Eichenauer et al.   HEMATOLOGICAL ONCOLOGY

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

(2011) D. A. Eichenauer et al.   BLOOD

Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

(2010) Mubarak Al-Mansour et al.   JOURNAL OF CLINICAL ONCOLOGY

Nodular, lymphocyte-predominant Hodgkin lymphoma

(2009) Irene Biasoli et al.   CANCER

Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group

(2007) Lucia Nogová et al.   JOURNAL OF CLINICAL ONCOLOGY